On the use of corticosteroids for critically ill patients with SARS-CoV-2 interstitial pneumonia
The health crisis caused by SARS-Cov2 continues to question the scientific community on an effective treatment to combat the disease. To do this, understanding the pathophysiology is a key element of the research. Although the use of corticosteroids is debated, recent publications on pathogenesis and histologic pattern allow us to consider their use on a different way. Through these two case reports, it seemed interesting to take stock of the most recent data in the literature and on the potential interest of the corticotherapy in specific critically ill patient's cases.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Revue medicale de Liege - 75(2020), S1 vom: 21., Seite 133-137 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
La corticothérapie chez le patient critique atteint d’une pneumopathie interstitielle à SARS-CoV-2 |
|---|
| Beteiligte Personen: |
Mingoia, A [VerfasserIn] |
|---|
| Themen: |
2 |
|---|
| Anmerkungen: |
Date Completed 23.11.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM317785737 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317785737 | ||
| 003 | DE-627 | ||
| 005 | 20231225164008.0 | ||
| 007 | tu | ||
| 008 | 231225s2020 xx ||||| 00| ||fre c | ||
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317785737 | ||
| 035 | |a (NLM)33211436 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Mingoia, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a On the use of corticosteroids for critically ill patients with SARS-CoV-2 interstitial pneumonia |
| 246 | 3 | 3 | |a La corticothérapie chez le patient critique atteint d’une pneumopathie interstitielle à SARS-CoV-2 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.11.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The health crisis caused by SARS-Cov2 continues to question the scientific community on an effective treatment to combat the disease. To do this, understanding the pathophysiology is a key element of the research. Although the use of corticosteroids is debated, recent publications on pathogenesis and histologic pattern allow us to consider their use on a different way. Through these two case reports, it seemed interesting to take stock of the most recent data in the literature and on the potential interest of the corticotherapy in specific critically ill patient's cases | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ARDS – AFOP | |
| 650 | 4 | |a Corticosteroids | |
| 650 | 4 | |a 2 | |
| 650 | 4 | |a CoV | |
| 650 | 4 | |a SARS | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Lejeune, F |e verfasserin |4 aut | |
| 700 | 1 | |a Sottiaux, T |e verfasserin |4 aut | |
| 700 | 1 | |a Van Brussel, C |e verfasserin |4 aut | |
| 700 | 1 | |a Adam, J F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue medicale de Liege |d 1947 |g 75(2020), S1 vom: 21., Seite 133-137 |w (DE-627)NLM000044490 |x 0370-629X |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2020 |g number:S1 |g day:21 |g pages:133-137 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2020 |e S1 |b 21 |h 133-137 | ||